Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2020 Jun 13.
Published in final edited form as: Chem. 2019 Apr 22;5(6):1584–1596. doi: 10.1016/j.chempr.2019.03.023

Expanding the materials space of DNA via organic-phase ring-opening metathesis polymerization

Xuyu Tan 1,1, Hao Lu 1,1, Yehui Sun 1, Xiaoying Chen 1, Dali Wang 1, Fei Jia 1, Ke Zhang 1,2,
PMCID: PMC6941852  NIHMSID: NIHMS1526210  PMID: 31903440

Summary:

Herein, we develop a facile route to bring DNA to the organic phase, which greatly expands the types of structures accessible using DNA macromonomers. Phosphotriester- and exocyclic amine-protected DNA was synthesized and further modified with a norbornene moiety, which enables homopolymerization via ring-opening metathesis to produce brush-type DNA graft polymers in high yields. Subsequent deprotection cleanly reveals the natural phosphodiester DNA. The method not only achieves high molecular weight DNA graft polymers but when carried out at low monomer:catalyst ratios, yields oligomers that can be further fractionated to molecularly pure, monodisperse entities with one through ten DNA strands per molecule. In addition, we demonstrate substantial simplification in the preparation of traditionally difficult DNA-containing structures, such as DNA/poly(ethylene glycol) diblock graft copolymers and DNA amphiphiles. We envision that the marriage of oligonucleotides with the vast range of organic-phase polymerizations will result in many new classes of materials with yet unknown properties.

Keywords: Oligonucleotide, ring-opening metathesis polymerization, graft polymer, spherical nucleic acids, pacDNA, DNA block copolymer

eTOC Blurb

Phosphate- and exocyclic amine-protected oligonucleotides are transformed into macromonomers for ring-opening metathesis polymerization in the organic phase. We demonstrate that homo- or copolymerization of the macromonomer followed by an “ultramild” deprotection step cleanly yields four distinct types of DNA-based structures: graft polymers, monodisperse oligomers, diblock graft copolymers, and diblock amphiphiles. These structures represent unprecedented or traditionally difficult DNA- containing polymers.

Graphical Abstract

graphic file with name nihms-1526210-f0001.jpg


Oligonucleotides have found extensive applications spanning structural DNA nanotechnology,13 materials assembly,4,5 DNA-encoded libraries,6,7 and nucleic acid-based medicine.8,9 In all of these fields it is often required for the oligonucleotide to be covalently attached to other moieties, be it a small molecule,1012 a macromolecule,13,14 a crosslinked network,15,16 or a nanoscopic/macroscopic surface.1719 These structures play irreplaceable roles in medicine, diagnostics, crystal engineering, drug discovery, among others.2024 The success of existing structures underscores the importance of developing new reactions and methods that can covalently arrange nucleic acids into a wide variety of well-defined architectures. Examining the chemical structure of the DNA conjugates reported thus far, two observations can be made, (i) Conjugates with a single oligonucleotide can be synthesized by solid-phase coupling or solution-phase coupling, (ii) Conjugates with multiple oligonucleotides are made by solution-phase coupling almost exclusively.25,26 These observations reveal an important limitation of the solid-phase methodology: architecturally complex structures involving multiple nucleic acid strands, such as high-density DNA graft polymers and crosslinked networks, are difficult, if not impossible, to achieve on a rigid, two-dimensional surface. Yet, nucleic acid-containing materials with a non-linear, three-dimensional architecture remain at the forefront of exploration in chemistry, materials science, and medicine.2729 Solution-phase coupling provides only partial access to these materials. For example, high-density, multivalent DNA constructs are difficult because of the strong electrostatic repulsion of the negatively charged DNA.3032 In addition, there is oftentimes a difficulty in finding a common solvent for the DNA and its hydrophobic conjugation partner.33,34

Among the non-linear architectures, brush-type oligonucleotides have attracted considerable attention due to the increased local nucleic acid density, which has been suggested as a factor that facilitates increased cellular endocytosis and enables carrier-free cellular gene regulation.35,36 Gianneschi et al. reported the organic-phase polymerization of peptide nucleic acids (PNAs) to prepare brush-type polymers, which takes advantage of the non-charged nature of PNAs and their solubility in dimethyl formamide (DMF).37 Nonetheless, the method cannot be readily extended to natural nucleic acids with phosphodiester backbones. Herrmann et al. adopted cationic surfactants for electrostatic complexation with DNA as a more general means to neutralize DNA negative charge and improve lipophilicity.38 Notwithstanding broader applicability, the reaction yields are moderate, especially for larger oligonucleotides/coupling partners and for polymerization. In addition, the complete removal of surfactants can be challenging. Herein, we report an approach to bypass the common limitations imposed by solubility and nucleobase side reactivities, and expand the toolbox for organic-phase manipulation of oligonucleotides. The method centers around the idea of separating the conventional, single-step reaction to cleave and deprotect the oligonucleotides following solid-phase synthesis into two steps, which allows for the release of nucleobase-protected, charge-masked strands to be used for homogeneous organic-phase reaction. While strategies to protect/deprotect nucleotides have been extensively studied for solid-phase oligonucleotide synthesis and other applications,3942 the use of protected oligonucleotides in polymer chemistry remains unexplored.

For a proof-of-concept demonstration, we adopted the ring-opening metathesis polymerization (ROMP) to facilely convert norbornene-modified, protected DNA (protDNA) in high yields into three distinct classes of polymer-DNA nanostructures: brush-type DNA graft polymers, DNA/poly(ethylene glycol) (PEG) diblock graft copolymers, and DNA block copolymer micelles, which represent traditionally challenging DNA nanostructures for aqueous- or solid-phase techniques (Figure 1). The homopolymerization of protDNA not only yields high molecular weight (Mw > 380 kDa) DNA graft polymers but can also be employed to prepare molecularly pure oligomeric DNA with one through ten strands per molecule when a low monomer;catalyst ratio is used. Previously, oligomeric DNA star polymers with four, eight, and twelve arms have been painstakingly synthesized via coupling with a careful selection of multivalent cores, followed by several rounds of HPLC purification.43 These monodisperse entities are scientifically valuable structures for accurately interrogating their interactions with living systems.44 In a single reaction, a full series of molecular oligomers (including all odd-numbered ones) up to a decamer is obtained, which allows us to unambiguously verify the DNA density effect on cellular uptake. We envision that the results reported herein are the proverbial tip of an iceberg in DNA-based polymers: the introduction of DNA as a common monomer to the vast knowledge base of polymer chemistry should result in unlimited possibilities.

Figure 1.

Figure 1.

Schematic representation of protDNA and its application in constructing DNA nanostructures.

Results and Discussion

Synthesis of the norbornenyl protDNA monomer.

The ester bond is a common base-labile linkage that tethers oligonucleotides to the controlled pore glass (CPG) for solid-phase oligonucleotide synthesis. Hydrolytic cleavage of the ester also results in the deprotection of the oligonucleotide. To release oligonucleotides in their protected form, a disulfide linker was used in place of the ester as it can be cleaved under soft reductive conditions. Tris-(2-carboxyethyl) phosphine (TCEP) quantitatively released the protected oligonucleotides from the CPG under weakly acidic conditions. The exposed sulfhydryl group was then used to couple with iodoacetyl- or maleimide-functionalized norbornene monomers via SN2 or Michael addition, respectively, to produce the protDNA monomers (Scheme S1). Neutral or slightly basic conditions (e.g. phosphate buffered saline (PBS), pH = 7.4) were required for efficient coupling with the iodoacetyl group, which led to some inadvertent deprotection of the protDNA (mainly the release of the 2-cyanoethyl group) and loss of solubility in organic solvents. As such, the maleimide-sulfhydryl coupling reaction was used in subsequent preparations. To screen for compatibility with the polymerization and deprotection chemistries, a range of phosphoramidites were tested in the synthesis of the protDNA. The “ultramild” phosphoramidites (phenoxyacetyl dA, 4-isopropyl-phenoxyacetyl dG, and acetyl dC) were ultimately selected due to a combination of improved solubility and milder deprotection conditions. One or two 12-methylene (C12) spacers were incorporated at the 3’ to reduce the steric hindrance of the protDNA monomer and facilitate polymerization. Notably, the solubility of protDNA in organic solvents was also improved by the spacer(s). Unless otherwise indicated, the following protDNA macromonomer was used in the polymerization studies: 5’-fluorescein-CTC CAT GGT GCT CAC-(C12)2-norbornene-3’ (Table S1). Electrospray ionization-mass spectrometry (ESI-MS) confirmed the successful synthesis of the protDNA macromonomer (exact mass: 8252.37 Da, calc. 8260.35 Da; Figure S1).

Homopolymerization of protDNA macromonomers.

Arranging DNA into a dense, highly oriented spherical form (termed spherical nucleic acids, or SNAs) can lead to the emergence of several unusual properties absent from linear or cyclic forms of DNA, such as increased binding affinity to a complementary strand and sharpening of the DNA melting transition (cooperative melting).27 Interestingly, the cellular uptake of SNAs is considerably elevated (by 2–3 orders of magnitude) over free DNA, despite SNAs’ polyanionic nature.27 It is not clear, however, whether there exists a distinct density threshold above which multivalent DNA structures behave like SNAs. The DNA graft polymers can in principle achieve SNA-like properties, and provide definitive answers to the density-uptake relationship question as density is a function of the degree of polymerization (DP), which is tunable. While post-polymerization “grafting-onto” chemistries can be used to access a similar architecture, incomplete grafting due to sterics and the strong charge repulsion ultimately results in limited DNA density.27,37 A “grafting-through” synthesis using norbornenyl protDNA should produce the highest possible DNA density achievable with graft polymers.

A panel of ROMP conditions were screened for compatibility with protDNA (Table S2). Ultimately, using 3rd-generation Grubbs’ catalyst to initiate the polymerization in dichloromethane (DCM) at −20 °C, near-quantitative conversion was achieved. Analyzing the raw mixture containing deprotected DNA graft polymers by polyacrylamide gel electrophoresis (PAGE), a collection of individual bands was observed, whichcan be assigned to specific degrees of polymerization (Figure 2a). Of note, while various ultramild deprotection conditions (e.g. K2CO3 in methanol and t-butylamine/methanol/water) can be used, some conditions also cleave the graft polymer side chains from the backbone via base-catalyzed retro-Michael reaction (Figure 2b).45 Partial cleavage results in lower-density graft polymers. Treatment with methanolic ammonia at 4 °C for 4 h was identified as capable of achieving full deprotection with minimal cleavage, as evidenced by aqueous gel permeation chromatography (GPC) and matrix-assisted laser-desorption ionization-time of flight mass spectrometry (Figures 2b and S2). The GPC peak for the graft polymer is symmetrical in shape (Figure S3), suggesting that chain-terminating events are much slower compared with propagation, and that protDNA iscompatible with the organoruthenium catalyst. Polymerizations with higher monomer:catalyst feed ratios resulted in higher DPs, as detected by GPC and PAGE (Figure 2cd), with polydispersity indices (PDIs) in therange of 1.37–1.48. Conversion remained ~90% when a 20:1 monomer:catalyst molar ratio was used, but dropped to 68% at 40:1, and 45% at 80:1 (Table S3). The reduced conversion at higher monomer:catalyst ratios limited the number-average DP (DPn) to ~45, which may be attributed to the steric hindrance of the bulky and stiff protDNA macromonomer, and/or the loss of solubility as the DP increases. The DNA graft polymers were purified by GPC, and their size/morphology were studied by transmission electron microscopy (TEM) and dynamic light scattering (DLS) (Figure 2e and Table S3). TEM images (negatively stained with 2% uranyl acetate) showed spherical or elliptical morphologies approximately 11–17 nm in diameter. DLS showed increasing number-average hydrodynamic diameters (Dh(n) 10–16 nm) with increasing DPn, and relatively unchanged ζ potential between −25 and −28 mV, corroborating TEM results (Table S3).

Figure 2.

Figure 2.

Characterization of DNA graft polymers, (a) PAGE of the raw reaction mixture after ROMP and deprotection (monomer;catalyst molar ratio: 5:1). (b) Deprotection conditions and their effect on the retention of DNA side chains as indicated by aqueous GPC. (c-d) Aqueous GPC chromatograms and PAGE of DNA graft polymers synthesized with increasing monomer initiator feed ratios, (e) Particle morphology observed under TEM. Samples were negatively stained with 2% uranyl acetate. Scale bar: 100 nm.

To further investigate whether the hybridization and dehybridization properties of DNA were influenced by the bottlebrush-like architecture, we adopted a fluorescence quenching assay, where a quencher (dabcyl)-modifιed strand is hybridized with a fluorescein-labeled DNA graft polymer. Hybridization and thermal melting result in decreases and increases of the fluorescence, respectively, and the rate of change reflects their kinetics. The hybridization kinetics of DNA graft polymers was initially as fast as that of the free DNA but slowed slightly as the reaction proceeded, taking longer to reach complete duplex formation. The trend is more obvious for graft polymers with larger DPs (Figure S4). The reduction in hybridization rate towards the end of the reaction may be attributed to the accumulation of negative charges on the nanostructure, which hinders subsequent reaction. On the other hand, thermal stability of DNA duplexes in the graft polymer form increased by ~3 °C compared with the free duplex, and with sharper melting transitions (Figure S5). Similar phenomena have been found with gold-cored SNAs, which can be explained by the elevated local salt concentration associated with densely arranged DNA.27,46 The increased salt concentration entropically stabilizes duplex DNA by masking their repulsive negative charges, resulting in higher melting temperatures. When a certain duplex within the nanostructure dehybridizes, salt concentration surrounding the duplex is reduced, making neighboring duplexes more prone to dissociate. These interpretations are in principle also applicable to the DNA graft polymers.

Monodisperse DNA oligomers and their cellular uptake.

By carrying out controlled polymerizations at low monomer:catalyst ratios, discreet oligomer libraries can be generated.47 The ROMP reaction of protDNA, therefore, can be a powerful method to produce monodisperse multivalent DNA. Octameric and dodecameric DNA have been meticulously synthesized previously by coupling linear DNA strands to a well-defined multivalent core, followed by several rounds of chromatographic purifications to remove partially coupled products.43 The monodisperse structures are poised to enable accurate interrogation of their interactions with living systems. However, due to the need to use a variety of cores to access a full numeric series of oligomers and the difficulty in synthesizing odd-valency cores, there has not been a conclusive study correlating cellular uptake and DNA density.43

In a single ROMP reaction of protDNA (carried out at 2:1 monomer:catalyst molar ratio), oligomeric DNA containing quantized numbers of strands, including all odd-numbered ones, were simultaneously synthesized, and PAGE was used to isolate monodisperse fractions containing unimers through decamers (limited by gel resolution, Figure 3ab). On the size-density map for SNAs reported thus far (Figure 3c), these molecular, monodisperse entities occupy a DNA density range (0.1–0.9 pmol/cm2) below that of common SNAs, while the polydisperse DNA graft polymers of higher DPs extend into the density range of prototypical SNAs (1.1–2.3 pmol/cm2). Thus, with identical chemical compositions, these well-defined structures allow us to unambiguously evaluate the effect of the DNA surface density on cellular uptake. Human ovarian carcinoma cells (SKOV-3) were treated with varying concentrations (up to 800 nM of DNA) of fluorescein-labeled, monodisperse oligomers as well as polydisperse graft polymers for 4 h, and were studied by confocal microscopy and flow cytometry. Confocal images showed increasing cell-associated fluorescence (mainly from endosomal compartments) with increasing DP (Figure 3d). Flow cytometry showed that the uptake increased linearly with concentration, suggesting that saturation in the uptake is far from being reached (Figures 3e, S6, and Table S4). The relative rate of cell uptake for the multivalent forms of DNA, as determined by the slope of the linear fit, is 90–170× greater than that of free DNA, and increases with increasing DPs. Strikingly, if one plots these slopes as a function of DNA surface density, another linear relationship comes into view (Figure 3f). The relative rate of uptake depends linearly with minimum variation (R2=0.994) on the DNA surface density in the monodisperse oligomer range, and the linear fit predicts the uptake of polydisperse graft polymers reasonably well. These results suggest that there is no threshold density for a multivalent DNA structure to behave like an SNA with regard to cellular uptake; the uptake instead increases cumulatively with increasing DNA surface density, starting as early as a dimer.

Figure 3.

Figure 3.

Characterization of monodisperse DNA oligomers and comparison with polydisperse graft polymers in cellular uptake, (a-b) PAGE and aqueous GPC chromatograms of purified DNA oligomers, (c) Size-density map of previously reported SNAs30,43,4851 and DNA graft polymers (with 2× C12 spacers) of varying DP. DNA surface density refers to the density at the outer surface of the particle as opposed to the footprint (see Experimental Procedures). Particle diameter is defined as the diameter of a spherical particle equivalent in volume to that of the graft polymers, which is estimated assuming all linkers and the polymer backbone are in the fully stretched conformation, (d) Laser-scanning confocal microscopy images of SKOV-3 cancer cells treated with different DNA graft polymers at an equal DNA concentration (800 nM; blue channel: DAPI; green channel: DNA). Imaging settings were kept identical for all samples. Scale bar: 20 μm. (e) Mean fluorescence of SKOV-3 cells treated with DNA graft polymers of varying DP as a function of incubation concentration (measured by flow cytometry; total cell counts: 10,000). The fitted slopes reflect the relative rates of cellular uptake, which are summarized in (f) as a function of DNA surface density. Errors (mean ± σ) in DNA surface density for polydisperse DNA graft polymers were calculated based upon aqueous GPC results.52

DNA/PEG diblock graft copolymers.

Covalent attachment of PEG remains a widely used technique to impart better pharmacokinetic properties to many forms of therapeutics. However, a single linear or slightly branched PEG, even with high molecular weight (40–100 kDa), cannot sufficiently shield oligonucleotides from interaction with serum or cell membrane proteins to provide appropriate biopharmaceutical properties for systemic use.53 Recently, we have developed a brush-architectured PEGylated oligonucleotide, termed pacDNA (polymer-assisted compaction of DNA), which consists of oligonucleotides tethered to the backbone of a PEG graft polymer with many (typically >25) shorter (5–10 kDa) PEG side chains.53,54 The highly branched achitecture provides a “Goldilocks” PEG density: high enough to reduce protein access but not too high to impair DNA hybridization with a complementary sequence.55 Such selectivity greatly diminishes unwanted side effects derived from DNA-protein interactions, and enhances pharmacokinetics.5659. The current synthesis of the pacDNA involves sequential copolymerization and post-polymerization modifications to obtain a diblock brush polymer, poly(oxanorbornenyl-azide)-b-(polynorbornene-g-PEG), onto which dibenzocyclooctyne (DBCO)-functionalized DNA strands are coupled via copper-free click chemistry.

With the ability to manipulate protDNA in organic solvents, it is possible to prepare pacDNA in one-pot by sequential copolymerization of norbornenyl PEG and protDNA (Figure 4a). Norbornenyl PEG (10 kDa) was polymerized as the first block using 3rd-generation Grubbs’ catalyst with a 30:1 monomer:catalyst molar ratio at −20 °C in DCM. Upon completion of the PEG block (monitored by GPC), protDNA monomers were introduced to the reaction mixture at a monomer:catalyst molar ratio of 2:1. Three protDNA monomers with zero to two C12 spacers were used to test the effect of linker length on the incorporation yield of protDNA. After deprotection with methanolic ammonia, aqueous GPC showed ~45%, 70%, and 70% incorporation for the protDNAs with zero, one, and two C12 linkers, respectively, indicating that the steric hindrance of protDNA during ROMP can be reduced by lengthening the spacing between norbornene and the protDNA. All three pacDNAs exhibited similar molecular weight (Mn ~250 kDa by aqueous GPC; Figures 4b and S7), number-average hydrodynamic size (−20.0 nm), ζ potential (~−4.0 mV) (Table S5), and morphology (spherical, as observed with TEM; see Figure 4c).

Figure 4.

Figure 4.

Synthesis and characterization of pacDNAs. (a) Synthetic scheme for the one-pot pacDNA. (b) PAGE of the pacDNAs with zero, one, and two C12 spacers. Samples form a non-penetrating band due to the large size and near-neutral charge, (c) Typical TEM image of the pacDNA (2× C12 spacer; stained with 2% uranyl acetate), showing a spherical morphology. Scale bar: 100 nm. (d) Enhanced nuclease stability of pacDNAs compared with free DNA. A shorter linker leads to better nuclease resistance.

Hybridization of the one-pot pacDNA with a dabcyl-labeled complementary strand is immediate and rapid, similar to that of free DNA and prototypical pacDNA (Figure S8). To examine the inhibition of protein access, pre-formed free DNA and pacDNA duplexes were treated with DNase I (an endonuclease that non-specifically cleaves dsDNA). Upon degradation, the fluorophore-quencher pair is separated, leading to an increase of fluorescence signal. It was found that all pacDNAs exhibited enhanced enzymatic stability compared to free DNA (2.7−7.8× longer half-life), and the stability increased with decreasing numbers of the C12 linker, which suggests a depth-effect with respect to the graft polymer backbone (Figure 4d).60 These results indicate that the one-pot pacDNA possesses the same hallmark features of traditional pacDNAs obtained via multi-step syntheses, and the proDNA approach can greatly shorten the synthetic route.

Amphiphilic DNA block copolymers.

DNA amphiphiles are yet another difficult-to-access class of structures using homogeneous coupling, especially those with a non-polar hydrophobic segment. To demonstrate the feasibility of using protDNA for the synthesis of DNA amphiphiles, two highly hydrophobic monomers (norbornenes coupled to a C12 aliphatic chain, C12NB, or pyrene, pyNB) were used to form the hydrophobic segment via ROMP (Figure 5a). A monomer:catalyst molar ratio of 10:1 was chosen to balance the amphiphilicity of the final copolymer so that micelles can be formed in an aqueous buffer. Once the monomers were consumed (monitored by TLC), a substantially sub-stoichiometric amount of protDNA monomers was added to the mixture. The large excess of the growing polymer chains ensures that amphiphiles containing only one DNA strand are statistically favored. After removal of the catalyst with ethyl vinyl ether (EVE) and deprotection of the protDNA with methanolic ammonia, unreacted polymers were removed by precipitation in water. Micelles suspended in the supernatant were further injected into an aqueous GPC to remove non-micellar residues (Figure S9). TEM showed that the poly(C12NB)-b-DNA and poly(pyNB)-b-DNA formed spherical micelles with dry-state diameters of 18.1 ± 4.6 nm and 15.4 ± 4.3 nm, respectively (Figure 5b), agreeing with DLS hydrodynamic size measurements (Dh(n) 23.1 ± 7.0 nm and 19.5 ± 6.8 nm, respectively) (Table S5). PAGE of the micelles exhibited band smearing, likely due to the dynamic nature of the assemblies (Figure 5c). For poly(pyNB)-b-DNA, the fluorescence emission spectrum of the micelle exhibited characteristic fluorescein (520 nm) and pyrene emissions (380 and 400 nm) (Figure S10). The micellar aggregation numbers were estimated from negatively stained TEM images, assuming the particle contrast is produced only by the hydrophobic core of the micelles. The C12- and pyrene-based micelles consist of −480 and −380 amphiphiles, respectively, which is comparable to other reported DNA micelles.36,61,62 It is possible that the actual aggregation number is lower than the estimate, due to incomplete removal of excess homopolymers from the reaction mixture. The micellar nanostructures are expected to exhibit SNA-like properties by virtue of their structural similarity. As a demonstration, we tested the nuclease stability of C12- and pyrene-based micelles by treating them with DNase I. The two micelles exhibited 3.9× and 4.5× longer half-lives than that of free DNA (Figure 5d), respectively, which is in line with typical for SNAs studies thus far.43,63

Figure 5.

Figure 5.

Synthesis and characterization of amphiphilic DNA block copolymers, (a) Synthetic scheme of DNA diblock amphiphiles. (b) Spherical micelles assembled from DNA diblock amphiphiles, as observed by TEM (with 2% uranyl acetate staining). Scale bar: 100 nm. (c) PAGE of the DNA micelles dispersed in PBS. The smearing of the bands is likely due to the dynamic nature of the supramolecular assemblies, (d) Increased nuclease resistance of the micelles compared with free duplexes, a hallmark feature of SNAs.

Conclusion

We demonstrate that, by separating the traditionally combined deprotection and cleavage reactions following solid-phase oligonucleotide synthesis into two steps, fully protected, hydrophobic oligonucleotides can be obtained, which enables further manipulation in organic solvents. Using the protected form of DNA, three distinct classes of DNA nanostructures (DNA graft polymers, pacDNAs, and micellar SNAs) can be obtained via ROMP in a one-pot fashion. These structures represent traditionally difficult DNA-based structures due to either architectural complexity or amphiphilicity. By turning DNA into an organics-soluble molecule, this study opens up promising possibilities to greatly expand the material space accessible to DNA. It is also possible to apply the technique to augment existing DNA-based applications, such as DNA-encoded libraries and DNA microarrays.

Experimental Procedures

Synthesis of the protDNA macromonomer.

Solid-phase oligonucleotide synthesis was conducted following standard protocols. After the completion of the synthesis (1 μmol scale), the CPG was air-dried and suspended in a solution containing 800 μL of acetonitrile and 400 μL of aqueous cleavage buffer (25 mg of TCEP•HCl and 15 mg of NaHCO3 in i960 μL Nanopure™ water). After shaking overnight at room temperature, 400 μL of Nanopure water™ was added to the solution and the CPG solid support was removed by filtration through a 0.45 μm polytetrafluoroethylene (PTFE) filter. The filtrate was then subjected to reverse-phase HPLC to separate thiolated protDNA monomer (C18 column; mobile phases: acetonitrile and pure water; flow rate: 1.0 mL/min; gradient: constant 50/50 vol% of acetonitrile/water from o to 5 min, then 100% acetonitrile for 30 min). The product was lyophilized and redissolved in a solvent consisting of 500 μL of acetonitrile and 500 μL of water. Next, 6 mg of the norbornenyl maleimide was added to the solution, and the mixture was vigorously shaken at 4 °C for 12 h. Last, the mixture was filtered and subjected to reverse-phase HPLC to separate the norbornenyl protDNA monomer from residues using the same gradient. Notably, the product exhibited multiple peaks in HPLC, which may be attributed to the chiral phosphate centers in the DNA backbone. The final solution was lyophilized to yield the protDNA monomer as a white powder.

Estimation of the DNA surface density.

Density is estimated at the outer periphery of the nanoparticle as opposed to the footprint where DNA meets with the polymer backbone. To establish a model for particle size, it is assumed that all chemical bonds in the polymer backbone and linkers are in the fully stretched conformation and occupy the maximum three-dimensional space. With this assumption, the central polymer backbone can be treated as a cylinder with the radius of R + r and a length of (DPn-1) × L, where R is the length of the DNA, r is the length of the linker, and L is the length of the repeating unit in the backbone. The DNA surface density is therefore a function of DPn:

DNAsurfacedensity(strand/nm2)=DPn2π(R+r)(DPn1)L+4π(R+r)2
1 strand/nm 2=[1mol/(6.022×1023)]/(107cm)2=166pmol/cm2
DNAsurfacedensity(pmol/cm2)=DPn2π(R+r)(DPn1)L+4π(R+r)2×166

where r and L are estimated to be 5.79 nm and 0.60 nm, respectively. The DNA has a 15-bp sequence and thus R = 0.34 nm × 15 = 5.1 nm. The calculated DNA surface densities are provided in Figure 3c.

Data availability.

All relevant data are available from the authors.

Supplementary Material

1

Highlights.

  • Chemically protected DNA was used for polymerization in the organic phase

  • Polymerization of DNA macromonomers gave DNA graft polymers in high yields

  • Monodisperse DNA oligomers, diblock grafts, and amphiphiles were also demonstrated

  • Cell uptake of multivalent DNA was shown to be linearly correlated with DNA density

Bigger Picture.

Short nucleic acid strands are a useful class of materials for a range of applications spanning medical diagnostics/therapeutics, DNA nanotechnology, and DNA-encoded libraries. Incorporation of them as a functional moiety with traditional polymers, however, proved to be difficult due to their insolubility in organic solvents and/or incompatible chemical properties with certain reactions. Overcoming these limitations, as reported herein, opens the door to a diverse range of novel, architecturally complex materials that are otherwise difficult or impossible to obtain. By expanding the materials space accessible to short nucleic acids, their technological potential are expected to be substantially increased.

Acknowledgements

Research reported in this publication was supported by the National Institutes of Health (the National Institute of General Medical Sciences Award Number 1R01GM121612–01) and the National Science Foundation (CAREER Award Number 1453255). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the National Science Foundation. We are grateful for the technical support from William Fowle and Dr. Michael Pollastri on TEM and LC-MS, respectively.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Declaration of Interests

K.Z. and X.T. are co-inventors on a pending U.S. non-provisional patent related to this work filed by Northeastern University (Application No.: 16/253,524, filed on 22 January 2019). All other authors declare no competing interests.

References and Notes

  • 1.Seeman NC (2005). Structural DNA nanotechnology: An overview. Methods Mol. Biol 303,143–166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Seeman NC (1996). The design and engineering of nucleic acid nanoscale assemblies. Curr. Opin. Struct. Biol 6, 519–526. [DOI] [PubMed] [Google Scholar]
  • 3.He L, Lu D, Liang H, Xie S, Zhang X, Liu Q, Yuan Q, and Tan W (2018). mRNA-initiated, three-dimensional DNA amplifier able to function inside living cells. J. Am. Chem. Soc 140, 258–263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Lu X, Watts E, Jia F, Tan X, and Zhang K (2014). Polycondensation of polymer brushes via DNA hybridization. J. Am. Chem. Soc 136,10214–10217. [DOI] [PubMed] [Google Scholar]
  • 5.Lin QY, Mason JA, Li Z, Zhou W, O’Brien MN, Brown KA, Jones MR, Butun S, Lee B, Dravid VP, et al. (2018). Building superlattices from individual nanoparticles via template-confined DNA-mediated assembly. Science 359, 669–672. [DOI] [PubMed] [Google Scholar]
  • 6.Favalli N, Bassi G, Scheuermann J, and Neri D (2018). DNA-encoded chemical libraries - achievements and remaining challenges. FEBS Letters 592, 2168–2180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Li G, Zheng W, Chen Z, Zhou Y, Liu Y, Yang J, Huang Y, and Li X (2015). Design, preparation, and selection of DNA-encoded dynamic libraries. Chem. Sci 6, 7097–7104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Chhabra R, Sharma J, Liu Y, Rinker S, and Yan H (2010). DNA self-assembly for nanomedicine. Adv. Drug Deliv. Rev 62, 617–625. [DOI] [PubMed] [Google Scholar]
  • 9.Campolongo MJ, Tan SJ, Xu J, and Luo D (2010). DNA nanomedicine: Engineering DNA as a polymer for therapeutic and diagnostic applications. Adv. Drug Deliv. Rev 62, 606–616. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Tan X, Li BB, Lu X, Jia F, Santori C, Menon P, Li H, Zhang B, Zhao JJ, and Zhang K (2015). Light-triggered, self-immolative nucleic acid-drug nanostructures. J. Am. Chem. Soc 137, 6112–6115. [DOI] [PubMed] [Google Scholar]
  • 11.Zhao N, Pei SN, Qi J, Zeng Z, Iyer SP, Lin P, Tung CH, and Zu Y (2015). Oligonucleotide aptamer-drug conjugates for targeted therapy of acute myeloid leukemia. Biomaterials 67, 42–51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Zou J, Jin C, Wang R, Kuai H, Zhang L, Zhang X, Li J, Qiu L, and Tan W (2018). Fluorinated DNA micelles: Synthesis and properties. Anal. Chem 90, 6843–6850. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Alemdaroglu FE, Ding K, Berger R, and Herrmann A (2006). DNA-templated synthesis in three dimensions: Introducing a micellar scaffold for organic reactions. Angew. Chem. Int. Ed. Engl 45, 4206–4210. [DOI] [PubMed] [Google Scholar]
  • 14.Jia F, Lu X, Tan X, and Zhang K (2015). Facile synthesis of nucleic acid-polymer amphiphiles and their self-assembly. Chem. Commun 51, 7843–7846. [DOI] [PubMed] [Google Scholar]
  • 15.Awino JK, Gudipati S, Hartmann AK, Santiana JJ, Cairns-Gibson DF, Gomez N, and Rouge JL (2017). Nucleic acid nanocapsules for enzyme-triggered drug release. J. Am. Chem. Soc 139, 6278–6281. [DOI] [PubMed] [Google Scholar]
  • 16.Li X, Figg CA, Wang R, Jiang Y, Lyu Y, Sun H, Liu Y, Wang Y, Teng IT, Hou W, et al. (2018). Cross-linked aptamer-lipid micelles for excellent stability and specificity in target-cell recognition. Angew. Chem. Int. Ed. Engl 57, 11589–11593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Zhu S, Xing H, Gordiichuk P, Park J, and Mirkin CA (2018). PLGA spherical nucleic acids. Adv. Mater 30, 61707113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Banga RJ, Krovi SA, Narayan SP, Sprangers AJ, Liu G, Mirkin CA, and Nguyen ST (2017). Drug-loaded polymeric spherical nucleic acids: Enhancing colloidal stability and cellular uptake of polymeric nanoparticles through DNA surface-functionalization. Biomacromolecules 18, 483–489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Beaucage SL (2001). Strategies in the preparation of DNA oligonucleotide arrays for diagnostic applications. Curr. Med. Chem 8,1213–1244. [DOI] [PubMed] [Google Scholar]
  • 20.Dobrovolskaia MA (2016). Self-assembled DNA/RNA nanoparticles as a new generation of therapeutic nucleic acids: Immunological compatibility and other translational considerations. DNA and RNA Nanotechnology 3,1–10. [Google Scholar]
  • 21.Yershov G, Barsky V, Belgovskiy A, Kirillov E, Kreindlin E, Ivanov I, Parinov S, Guschin D, Drobishev A, Dubiley S, et al. (1996). DNA analysis and diagnostics on oligonucleotide microchips. Proc. Natl. Acad. Sci. U.S.A. 93, 4913–4918. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Mirkin CA, Letsinger RL, Mucic RC, and Storhoff JJ (1996). A DNA-based method for rationally assembling nanoparticles into macroscopic materials. Nature 382, 607–609. [DOI] [PubMed] [Google Scholar]
  • 23.Macfarlane RJ, Lee B, Jones MR, Harris N, Schatz GC, and Mirkin CA (2011). Nanoparticle superlattice engineering with DNA. Science 334, 204–208. [DOI] [PubMed] [Google Scholar]
  • 24.Goodnow RA, and Davie CP (2017). Chapter One - DNA-encoded library technology: A brief guide to its evolution and impact on drug discovery In Annual Reports in Medicinal Chemistry, Goodnow RA, ed. (Academic Press; ), pp. 1–15. [Google Scholar]
  • 25.Singh Y, Murat P, and Defrancq E (2010). Recent developments in oligonucleotide conjugation. Chem. Soc. Rev 39, 2054–2070. [DOI] [PubMed] [Google Scholar]
  • 26.Juliano RL, Ming X, and Nakagawa O (2012). The chemistry and biology of oligonucleotide conjugates. Acc. Chem. Res 45,1067–1076. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Cutler JI, Auyeung E, and Mirkin CA (2012). Spherical nucleic acids. J. Am. Chem. Soc 134,1376–1391. [DOI] [PubMed] [Google Scholar]
  • 28.Wang P, Meyer TA, Pan V, Dutta PK, and Ke Y (2017). The beauty and utility of DNA origami. Chem 2, 359–382. [Google Scholar]
  • 29.Li J, Pei H, Zhu B, Liang L, Wei M, He Y, Chen N, Li D, Huang Q, and Fan C (2011). Self-assembled multivalent DNA nanostructures for noninvasive intracellular delivery of immunostimulatory CpG oligonucleotides. ACS Nano 5, 8783–8789. [DOI] [PubMed] [Google Scholar]
  • 30.Hurst SJ, Lytton-Jean AK, and Mirkin CA (2006). Maximizing DNA loading on a range of gold nanoparticle sizes. Anal. Chem 78, 8313–8318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Liu B, and Liu J (2017). Methods for preparing DNA-functionalized gold nanoparticles, a key reagent of bioanalytical chemistry. Anal. Methods 9, 2633–2643. [Google Scholar]
  • 32.Sun D, and Gang O (2013). DNA-functionalized quantum dots: Fabrication, structural, and physicochemical properties. Langmuir 29, 7038–7046. [DOI] [PubMed] [Google Scholar]
  • 33.Winkler J (2013). Oligonucleotide conjugates for therapeutic applications. Ther. Deliv 4, 791–809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Kwak M, and Herrmann A (2011). Nucleic acid amphiphiles: Synthesis and self-assembled nanostructures. Chem. Soc. Rev 40, 5745–5755· [DOI] [PubMed] [Google Scholar]
  • 35.Choi CH, Hao L, Narayan SP, Auyeung E, and Mirkin CA (2013). Mechanism for the endocytosis of spherical nucleic acid nanoparticle conjugates. Proc. Natl. Acad. Sci. U.S.A. 110, 7625–7630. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Tan X, Lu X, Jia F, Liu X, Sun Y, Logan JK, and Zhang K (2016). Blurring the role of oligonucleotides: Spherical nucleic acids as a drug delivery vehicle. J. Am. Chem. Soc 138,10834–10837. [DOI] [PubMed] [Google Scholar]
  • 37.James CR, Rush AM, Insley T, Vukovic L, Adamiak L, Krai P, and Gianneschi NC (2014). Poly(oligonucleotide). J. Am. Chem. Soc 136,11216–11219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Liu K, Zheng L, Liu Q, de Vries JW, Gerasimov JY, and Herrmann A (2014). Nucleic acid chemistry in the organic phase: From functionalized oligonucleotides to DNA side chain polymers. J. Am. Chem. Soc 136,14255–14262. [DOI] [PubMed] [Google Scholar]
  • 39.Sonveaux E (1994). Protecting groups in oligonucleotide synthesis. Methods Mol. Biol 26,1–71. [DOI] [PubMed] [Google Scholar]
  • 40.Somoza A (2008). Protecting groups for RNA synthesis: An increasing need for selective preparative methods. Chem. Soc. Rev 37, 2668–2675. [DOI] [PubMed] [Google Scholar]
  • 41.McMinn DL, and Greenberg MM (1998). Postsynthetic conjugation of protected oligonucleotides containing 3’-alkylamines. J. Am. Chem. Soc 120, 3289–3294. [Google Scholar]
  • 42.Lindström UM, and Kool ET (2002). An orthogonal oligonucleotide protecting group strategy that enables assembly of repetitive or highly structured DNAs. Nucleic Acids Res. 30, eioi. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Li H, Zhang B, Lu X, Tan X, Jia F, Xiao Y, Cheng Z, Li Y, Silva DO, Schrekker HS, et al. (2018). Molecular spherical nucleic acids. Proc. Natl. Acad. Sci. U.S.A. 115, 4340–4344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Nakayama Y (2012). Hyperbranched polymeric “star vectors” for effective DNA or siRNA delivery. Acc. Chem. Res 45, 994–1004. [DOI] [PubMed] [Google Scholar]
  • 45.Szijj PA, Bahou C, and Chudasama V (2018). Minireview: Addressing the retro-Michael instability of maleimide bioconjugates. Drug Discov. Today: Technologies 30, 27–34. [DOI] [PubMed] [Google Scholar]
  • 46.Randeria PS, Jones MR, Kohlstedt KL, Banga RJ, Olvera de la Cruz M, Schatz GC, and Mirkin CA (2015). What controls the hybridization thermodynamics of spherical nucleic acids? J. Am. Chem. Soc 137, 3486–3489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Lawrence J, Lee SH, Abdilla A, Nothling MD, Ren JM, Knight AS, Fleischmann C, Li Y, Abrams AS, Schmidt BV, et al. (2016). A versatile and scalable strategy to discrete oligomers. J. Am. Chem. Soc 138, 6306–6310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Banga RJ, Chernyak N, Narayan SP, Nguyen ST, and Mirkin CA (2014). Liposomal spherical nucleic acids. J. Am. Chem. Soc 136, 9866–9869. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Sprangers AJ, Hao L, Banga RJ, and Mirkin CA (2017). Liposomal spherical nucleic acids for regulating long noncoding RNAs in the nucleus. Small 13,1602753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Brodin JD, Sprangers AJ, McMillan JR, and Mirkin CA (2015). DNA-mediated cellular delivery of functional enzymes. J. Am. Chem. Soc 137,14838–14841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Morris W, Briley WE, Auyeung E, Cabezas MD, and Mirkin CA (2014). Nucleic acid-metal organic framework (MOF) nanoparticle conjugates. J. Am. Chem. Soc 136, 7261–7264. [DOI] [PubMed] [Google Scholar]
  • 52.Doncom KEB, Blackman LD, Wright DB, Gibson MI, and O’Reilly RK (2017). Dispersity effects in polymer self-assemblies: A matter of hierarchical control. Chem. Soc. Rev 46, 4119–4134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Lu X, and Zhang K (2018). PEGylation of therapeutic oligonucletides: From linear to highly branched PEG architectures. Nano Research 11, 5519–5534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Lu X, Tran TH, Jia F, Tan X, Davis S, Krishnan S, Amiji MM, and Zhang K (2015). Providing oligonucleotides with steric selectivity by brush-polymer-assisted compaction. J. Am. Chem. Soc 137, 12466–12469. [DOI] [PubMed] [Google Scholar]
  • 55.Wang D, Lu X, Jia F, Tan X, Sun X, Cao X, Wai F, Zhang C, and Zhang K (2017). Precision tuning of DNA- and poly(ethylene glycol)-based nanoparticles via coassembly for effective antisense gene regulation. Chem. Mater 29, 9882–9886. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Wang D, Lin J, Jia F, Tan X, Wang Y, Sun X, Cao X, Che F, Lu H, Gao X, et al. (2019). Bottlebrush-architectured poly(ethylene glycol) as an efficient vector for RNA interference in vivo. Sci. Adv 5, DOI: 10.1126/sciadv.aav9322 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Jia F, Wang D, Lu X, Tan X, Wang Y, Lu H, and Zhang K (2018). Improving the enzymatic stability and the pharmacokinetics of oligonucleotides via DNA-backboned bottlebrush polymers. Nano Lett. 18, 7378–7382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Lu X, Jia F, Tan X, Wang D, Cao X, Zheng J, and Zhang K (2016). Effective antisense gene regulation via noncationic, polyethylene glycol brushes. J. Am. Chem. Soc 138, 9097–9100. [DOI] [PubMed] [Google Scholar]
  • 59.Cao X, Lu X, Wang D, Jia F, Tan X, Corley M, Chen X, and Zhang K (2017). Modulating the cellular immune response of oligonucleotides by brush polymer-assisted compaction. Small 13, DOI: 10.1002/smll.201701432 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Jia F, Lu X, Wang D, Cao X, Tan X, Lu H, and Zhang K (2017). Depth-profiling the nuclease stability and the gene silencing efficacy ofbrush-architectured poly(ethylene glycol)-DNA conjugates. J. Am. Chem. Soc 139,10605–10608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Lee S, Yoon JH, Jo IS, Oh JS, Pine DJ, Shim TS, and Yi GR (2018). DNA-functionalized 100 nm polymer nanoparticles from block copolymer micelles. Langmuir 34,11042–11048. [DOI] [PubMed] [Google Scholar]
  • 62.Alemdaroglu FE, Alemdaroglu NC, Langguth P, and Herrmann A (2008). DNA block copolymer micelles - A combinatorial tool for cancer nanotechnology. Adv. Mater 20, 899–902. [Google Scholar]
  • 63.Rush AM, Thompson MP, Tatro ET, and Gianneschi NC (2013). Nuclease-resistant DNA via high-density packing in polymeric micellar nanoparticle coronas. ACS Nano 7,1379–1387. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1

Data Availability Statement

All relevant data are available from the authors.

RESOURCES